Table 1 Baseline characteristics of study population.
Characteristics | Total (n = 304) | No CRBSI (n = 280) | CRBSI(n = 24) | P | X2 |
|---|---|---|---|---|---|
Gender | 0.400 | 0.707 | |||
Male | 178 | 162 | 16 | ||
Female | 126 | 118 | 8 | ||
Age (m)[M(P25,P75)] | 24(6, 81) | 12(3.25, 99) | 0.49# | ||
Underlying disease | 0.395 | 10.532 | |||
Tumor | 51 | 45 | 6 | ||
Neurologic disease | 46 | 39 | 7 | ||
Respiratory disease | 22 | 19 | 3 | ||
Digestive disease | 17 | 17 | 0 | ||
Cardiovascular disease | 117 | 112 | 5 | ||
Congenital malformation | 44 | 22 | 2 | ||
Sepsis | 10 | 9 | 1 | ||
Hematological disease | 5 | 5 | 0 | ||
Catheter type | 0.38 | 0.772 | |||
Product A | 190 | 17 | 173 | ||
Product B | 114 | 7 | 107 | ||
Add-on devices (after insertion) | |||||
Number of multilumen extension sets | 0.512 | 1.340 | |||
0 | 31 | 27 | 4 | ||
1 | 271 | 251 | 20 | ||
2 | 2 | 2 | 0 | ||
Number of single lumen extension sets | 0.678 | 0.173 | |||
0 | 302 | 278 | 24 | ||
1 | 2 | 2 | 0 | ||
Number of 3-way stopcocks | 0.215 | 1.537 | |||
0–3 | 179 | 162 | 17 | ||
4–8 | 125 | 118 | 7 | ||
